5 reports

One treatment group will receive one injection of high dose vaccine, the other two groups will receive two shots of either high dose or low dose vaccine.

  • Pathology
  • Therapy
  • Vaccine
  • Austria
  • Themis Bioscience GmbH
  • PARTNERSHIPS

This agreement enables JSW to extend efficacy studies for anti-amyloid strategies into very early stage of development of pathology in in-vivo studies.

  • Mental Health
  • Pathology
  • Pharmaceutical
  • Austria
  • Deals & Alliance

One treatment group will receive one injection of high dose vaccine, the other two groups will receive two shots of either high dose or low dose vaccine.

  • Pathology
  • Therapy
  • Vaccine
  • Austria
  • Themis Bioscience GmbH

The organization works in collaboration with the Research Institute of Molecular Pathology, Boehringer' s basic research center.

  • Pathology
  • Pharmaceutical
  • Therapy
  • Austria
  • Apeiron Biologics AG
  • MAR 23, 2018: BREAST CANCER: NEW MECHANISM DISCOVERED FOR DISSEMINATION OF METASTATIC TUMOUR CELLS
  • GOVERNMENT AND PUBLIC INTEREST

The organization works in collaboration with the Research Institute of Molecular Pathology, Boehringer' s basic research center.

  • Healthcare
  • Medical Biotechnology
  • Pathology
  • Pharmaceutical
  • Austria